Immune Tolerance Induction with Nuwiq® (Simoctocog Alfa) in Nine Patients with Severe Haemophilia A and Inhibitors to FVIII
Ri J Liesner1, Alice Wilkinson2, Mary Mathias1, Neha Bhatnagar2, Tina Biss2, Georgina W...
Read More
Author: Hayley Frost
Combination of emicizumab with simoctocog alfa for prophylaxis in previously untreated/minimally treated hemophilia A patients, and for managing inhibitor patients
Robert Sidonio1, Shannon Meeks1, Amy Shapiro2, Marilyn Manco-Johnson3 and Michael Callaghan41Emory...
Read More
MOTIVATE: MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A – An international observational study
Carmen Escuriola Ettingshausen1, Robert F. Sidonio, Jr.2, Johannes Oldenburg3, Behnaz...
Read More
Observational immune tolerance induction study (ObsITI): Immune tolerance induction with a single factor VIII/von Willebrand factor concentrate for treatment of haemophilia A patients with inhibitors
Carmen Escuriola Ettingshausen1 on behalf of the ObsITI Study Group1HZRM Hämophilie Zentrum Rhein...
Read More
Final results from the NuProtect study of Nuwiq® (simoctocog alfa) treatment in previously untreated patients with severe haemophilia A
R.J. Liesner1, M. Jansen2, S. Knaub31Great Ormond Hospital for Children NHS Trust Haemophilia...
Read More